According to ShibDaily, Apple Inc. has partnered with neurotechnology company Synchron to develop innovative products like iPhones and iPads that can be operated through brain implants. This collaboration marks a significant advancement in integrating neural interfaces with everyday devices, aiming to assist individuals with physical disabilities in controlling their Apple devices using thought commands. The technology utilizes Synchron’s stent-like implant, positioned on the motor cortex of the brain, to facilitate seamless interaction with iPhones and iPads via neural signals.
The device, known as Stentrode, captures motor signals from the brain and transmits them wirelessly to an external processor, which then translates these signals into commands for electronic devices. Apple and Synchron plan to enhance the tech giant’s existing assistive switch control system, which allows users with limited mobility to operate iPhones hands-free through simple gestures like head movements or silent sounds. This collaboration seeks to broaden accessibility options by integrating brain-controlled commands with established device controls.
Individuals with conditions such as amyotrophic lateral sclerosis (ALS) or severe spinal cord injuries may experience significant improvements in their ability to operate smartphones and tablets using thought alone, eliminating the need for physical movement. Additionally, future users of the Stentrode device will avoid open brain surgery, as Synchron describes the technology as a minimally invasive and scalable brain-computer interface (BCI). Synchron co-founder Tom Oxley stated, “With BCI recognized as a native input for Apple devices, there are new possibilities for people living with paralysis and beyond.” He added that Apple is pioneering a new interface paradigm where brain signals are formally recognized alongside touch, voice, and typing.
Limited trials involving Apple’s iPhones, iPads, and Apple Vision Pro mixed-reality headsets are set to begin with select participants later this year. As Apple and Synchron proceed with these trials, the collaboration could represent a significant milestone in merging neuroscience and consumer technology, potentially redefining how users interact with digital devices in the near future.
